CATCH-R: A Rollover Study to Provide Continued Access to Rucaparib

Summary

This protocol is designed to provide participants currently benefiting from rucaparib treatment in a Clovis-sponsored clinical study with continued access to treatment for as long as they continue to benefit. Participants in long-term follow-up (LTFU) in a parent study may also enroll in this study for continued data collection, as applicable based on parent study objectives.

Timeline

Start

2021-03-22

Primary completion

2023-03-08

Completion

2023-03-08

Drugs

Indications